Compare AZN & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MS |
|---|---|---|
| Founded | 1992 | 1924 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 278.4B |
| IPO Year | N/A | N/A |
| Metric | AZN | MS |
|---|---|---|
| Price | $208.86 | $176.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | N/A | ★ $176.00 |
| AVG Volume (30 Days) | 1.6M | ★ 7.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.51% | ★ 2.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.84 | $11.89 |
| Revenue Next Year | $6.16 | $5.36 |
| P/E Ratio | $32.35 | ★ $17.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $122.26 | $94.33 |
| 52 Week High | $212.19 | $192.68 |
| Indicator | AZN | MS |
|---|---|---|
| Relative Strength Index (RSI) | 87.12 | 47.35 |
| Support Level | $187.06 | $163.59 |
| Resistance Level | $193.97 | $184.58 |
| Average True Range (ATR) | 4.23 | 6.38 |
| MACD | 4.29 | -1.04 |
| Stochastic Oscillator | 96.80 | 51.61 |
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.